Otonomy to Participate in the H.C. Wainwright BioConnect Conference

Rhea-AI Summary

Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company focused on neurotology, will participate in the H.C. Wainwright BioConnect Virtual Conference. A pre-recorded presentation from the management team will be available on January 10, 2022, starting at 7 a.m. ET / 4 a.m. PT. Interested viewers can access the presentation via the conference website or through the company's Events page.

Otonomy’s innovative drug delivery technology targets hearing loss and tinnitus, aiming to meet critical medical needs.

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its participation in the H.C. Wainwright BioConnect Virtual Conference. A pre-recorded company presentation by the Otonomy management team will be available on the conference website beginning at 7 a.m. ET / 4 a.m. PT on January 10, 2022.

A link to the presentation will also become available at the same time through the Events page of the company's website (www.otonomy.com).

About Otonomy

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs with a focus on hearing loss and tinnitus. For additional information please visit www.otonomy.com.

Contacts:

Media Inquiries:
Spectrum Science
Chloé-Anne Ramsey
Vice President
404.865.3601
cramsey@spectrumscience.com

Investor Inquiries:
Westwicke ICR
Robert H. Uhl
Managing Director
858.356.5932
robert.uhl@westwicke.com

FAQ

What is Otonomy's participation in the H.C. Wainwright BioConnect Virtual Conference?

Otonomy will present a pre-recorded session on January 10, 2022, available from 7 a.m. ET / 4 a.m. PT.

Where can I watch Otonomy's conference presentation?

The presentation will be accessible on the conference website and via Otonomy's Events page.

What innovative technology does Otonomy focus on?

Otonomy specializes in drug delivery technology for the ear, targeting hearing loss and tinnitus.

What is the ticker symbol for Otonomy?

Otonomy trades under the ticker symbol OTIC on the Nasdaq.

When will Otonomy's presentation be available online?

The presentation will be available online starting January 10, 2022, at 7 a.m. ET.